RxSight, Inc. to Present at the Bank of America Healthcare Conference
RxSight (NASDAQ:RXST) will present at the Bank of America Healthcare Conference on Wednesday, May 13, 2026 at 3:00 p.m. PT.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
RxSight (NASDAQ:RXST) will present at the Bank of America Healthcare Conference on Wednesday, May 13, 2026 at 3:00 p.m. PT. Management will take part in a fireside chat. A live and archived webcast will be available on the company’s investor relations website.
Details
News Market Reaction – RXST
On Apr 30, the first trading day after this news, RXST closed 3.82% above the previous close.
Data tracked by StockTitan Argus for the Apr 30 session.
Key Figures
- Conference fireside chat time
- 3:00 p.m. Pacific Time
- Bank of America Healthcare Conference on May 13, 2026
Historical Context
-
Set timing for Q1 2026 results and conference call logistics.
-
Surpassed 300,000 LAL implants and highlighted ASCRS 2026 presence.
-
Announced fireside chat at Needham Virtual Healthcare Conference.
-
Reported 2025 results and 2026 guidance with net loss and revenue drop.
-
Announced date and time for Q4 and full-year 2025 results call.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
ALISO VIEJO, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc., today announced plans to participate in the upcoming Bank of America Healthcare Conference. Management is scheduled to participate in a fireside chat on Wednesday, May 13, 2026, at 3:00 p.m. Pacific Time. A live and archived webcast of the presentation will be available on the company’s investor relations website at https://investors.rxsight.com/.
About RxSight, Inc.
RxSight, Inc. is an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery. The RxSight® Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens® (LAL®/LAL+®, collectively the “LAL”), RxSight Light Delivery Device (LDD™) and accessories, is the first and only commercially available intraocular lens (IOL) technology that can be adjusted after surgery, enabling doctors to customize and deliver high-quality vision to patients after cataract surgery. Additional information about RxSight can be found at www.rxsight.com.
Investor Relations Contact:
Oliver Moravcevic
VP, Investor Relations
omoravcevic@rxsight.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.